Literature DB >> 29509752

An immunosuppressive pathway for tumor progression.

Antoine Marçais1, Thierry Walzer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29509752     DOI： 10.1038/nm.4508

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

1.  Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT.

Authors:  Srinivas Malladi; Danilo G Macalinao; Xin Jin; Lan He; Harihar Basnet; Yilong Zou; Elisa de Stanchina; Joan Massagué
Journal:  Cell       Date:  2016-03-24       Impact factor: 41.582

Review 2.  The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.

Authors:  James W T Toh; Paul de Souza; Stephanie H Lim; Puneet Singh; Wei Chua; Weng Ng; Kevin J Spring
Journal:  Clin Colorectal Cancer       Date:  2016-07-22       Impact factor: 4.481

3.  GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity.

Authors:  Frank Cichocki; Bahram Valamehr; Ryan Bjordahl; Bin Zhang; Betsy Rezner; Paul Rogers; Svetlana Gaidarova; Stacey Moreno; Katie Tuininga; Phillip Dougherty; Valarie McCullar; Peter Howard; Dhifaf Sarhan; Emily Taras; Heinrich Schlums; Stewart Abbot; Daniel Shoemaker; Yenan T Bryceson; Bruce R Blazar; Scott Wolchko; Sarah Cooley; Jeffrey S Miller
Journal:  Cancer Res       Date:  2017-08-08       Impact factor: 12.701

Review 4.  Immune checkpoints and their inhibition in cancer and infectious diseases.

Authors:  Lydia Dyck; Kingston H G Mills
Journal:  Eur J Immunol       Date:  2017-04-24       Impact factor: 5.532

5.  PD-1 increases PTEN phosphatase activity while decreasing PTEN protein stability by inhibiting casein kinase 2.

Authors:  Nikolaos Patsoukis; Lequn Li; Duygu Sari; Victoria Petkova; Vassiliki A Boussiotis
Journal:  Mol Cell Biol       Date:  2013-06-03       Impact factor: 4.272

Review 6.  Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.

Authors:  Roel Nusse; Hans Clevers
Journal:  Cell       Date:  2017-06-01       Impact factor: 41.582

7.  DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation.

Authors:  Qian Xiao; Jibo Wu; Wei-Jia Wang; Shiyang Chen; Yingxia Zheng; Xiaoqing Yu; Katrina Meeth; Mahnaz Sahraei; Alfred L M Bothwell; Lieping Chen; Marcus Bosenberg; Jianfeng Chen; Veronika Sexl; Le Sun; Lin Li; Wenwen Tang; Dianqing Wu
Journal:  Nat Med       Date:  2018-02-12       Impact factor: 53.440

8.  The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.

Authors:  Julien Cherfils-Vicini; Charlotte Viant; Antoine Marçais; Sophie Degouve; Sébastien Viel; Aurore Fenis; Jessica Rabilloud; Katia Mayol; Armelle Tavares; Jacques Bienvenu; Yann-Gaël Gangloff; Eric Gilson; Eric Vivier; Thierry Walzer
Journal:  Nat Immunol       Date:  2014-06-29       Impact factor: 25.606

Review 9.  GSK-3 as potential target for therapeutic intervention in cancer.

Authors:  James A McCubrey; Linda S Steelman; Fred E Bertrand; Nicole M Davis; Melissa Sokolosky; Steve L Abrams; Giuseppe Montalto; Antonino B D'Assoro; Massimo Libra; Ferdinando Nicoletti; Roberta Maestro; Jorg Basecke; Dariusz Rakus; Agnieszka Gizak; Zoya N Demidenko; Lucio Cocco; Alberto M Martelli; Melchiorre Cervello
Journal:  Oncotarget       Date:  2014-05-30

10.  Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer.

Authors:  Lucia D'Amico; Sahil Mahajan; Aude-Hélène Capietto; Zhengfeng Yang; Ali Zamani; Biancamaria Ricci; David B Bumpass; Melissa Meyer; Xinming Su; Andrea Wang-Gillam; Katherine Weilbaecher; Sheila A Stewart; David G DeNardo; Roberta Faccio
Journal:  J Exp Med       Date:  2016-04-04       Impact factor: 14.307
View more
  2 in total

Review 1.  Integrating Immunology and Microfluidics for Single Immune Cell Analysis.

Authors:  Nidhi Sinha; Nikita Subedi; Jurjen Tel
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

2.  Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer.

Authors:  Qiaoqi Chen; Liang Zhang; Lin Li; Mixiao Tan; Weiwei Liu; Shuling Liu; Zhuoyan Xie; Wei Zhang; Zhigang Wang; Yang Cao; Tingting Shang; Haitao Ran
Journal:  J Nanobiotechnology       Date:  2021-12-24       Impact factor: 10.435
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.